Experience

The Clinical Area, especially in relation to the knowledge of Cancer and its congenital and hereditary characteristics, has been the highest aspiration of Dr. Daniel Rueda Fernández. After a long and extensive professional career dedicated to research, he has reached the position of Director of the Biomarker Discovery and Pharmacogenomics Unit at the prestigious company PharmaMar, a pioneer for more than 30 years in the development of novel drugs of marine origin for the fight against cancer.  

All this, backed by an unparalleled academic career, which highlights his outstanding Cum Laude thesis in Biochemistry and Molecular Biology. In addition, he has been the author of dozens of articles, published and indexed in prestigious media in the scientific sector.

  • Head of the Biomarker Discovery and Pharmacogenomics Unit at PharmaMar
  • Head of Genetic Studies in Hereditary Cancer at 12 de Octubre University Hospital
  • Molecular Biologist at Gemolab S.L. 
  • Research Scientist at Sylentis 
  • PhD in Biochemistry and Molecular Biology from the Complutense University of Madrid (UCM)
  • Degree in Biochemistry from the Complutense University of Madrid (UCM)
Programmes in collaboration with

1 /